Peter L. Ginsberg
Directeur des opérations chez The Foundation Fighting Blindness, Inc.
Profil
Peter L.
Ginsberg is the founder of Opus Genetics, Inc. (founded in 2021).
He currently holds the position of Treasurer & Director at First Flight Venture Center, Inc. and Chief Operating Officer at The Foundation Fighting Blindness, Inc. (since 2022).
Previously, he worked as a Managing Director at Piper Sandler & Co. (Broker) from 1970 to 2003.
He also held positions at Surmodics, Inc., United Therapeutics Corp., BioDelivery Sciences International, Inc., Deephaven Capital Management LLC, and Savara, Inc. (Vice President-Business Development from 2018 to 2020).
Mr. Ginsberg received his undergraduate degree from Princeton University in 1987 and an MBA from the Tuck School of Business at Dartmouth.
Postes actifs de Peter L. Ginsberg
| Sociétés | Poste | Début |
|---|---|---|
First Flight Venture Center, Inc.
 First Flight Venture Center, Inc. Miscellaneous Commercial ServicesCommercial Services First Flight Venture Center operates as a non-profit organization that provides business support services to start-up and early stage companies. It offers programs for technology companies that help them in fields such as concept testing, prototyping, research, business strategies, and product development. The company was founded in 1991 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Directeur des opérations | 13/09/2022 |
Anciens postes connus de Peter L. Ginsberg
| Sociétés | Poste | Fin |
|---|---|---|
| SAVARA INC. | Corporate Officer/Principal | 01/11/2020 |
Deephaven Capital Management LLC
 Deephaven Capital Management LLC Investment ManagersFinance Deephaven Capital Management LLC performs investment management services and sponsors a private investment fund, the Deephaven fund, for institutions and high-net-worth individuals. The Minnetonka, Minnesota-based firm is a subsidiary of Knight Trading Group, Inc. (NASDAQ: NITE) | Analyst-Equity | 30/04/2006 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Analyst-Equity | 06/03/2003 |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Corporate Officer/Principal | 01/01/2003 |
Opus Genetics, Inc.
 Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Fondateur | - |
Formation de Peter L. Ginsberg
| Princeton University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SURMODICS, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Deephaven Capital Management LLC
Deephaven Capital Management LLC Investment ManagersFinance Deephaven Capital Management LLC performs investment management services and sponsors a private investment fund, the Deephaven fund, for institutions and high-net-worth individuals. The Minnetonka, Minnesota-based firm is a subsidiary of Knight Trading Group, Inc. (NASDAQ: NITE) | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Finance |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
First Flight Venture Center, Inc.
First Flight Venture Center, Inc. Miscellaneous Commercial ServicesCommercial Services First Flight Venture Center operates as a non-profit organization that provides business support services to start-up and early stage companies. It offers programs for technology companies that help them in fields such as concept testing, prototyping, research, business strategies, and product development. The company was founded in 1991 and is headquartered in Durham, NC. | Commercial Services |
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Health Technology |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Commercial Services |